Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma.

Zeng, Zhiyong; Lin, Junfang; Zhang, Kejie; Guo, Xizhe; Zheng, Xiaoqiang; Yang, Apeng; Chen, Junmin

Zeng, Zhiyong; Lin, Junfang; Zhang, Kejie; Guo, Xizhe; Zheng, Xiaoqiang; Yang, Apeng; Chen, Junmin.

Afiliación

Zeng Z; Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Lin J; Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Zhang K; Department of Hematology, Zhongshan Hospital Xiamen University, Xiamen, China.
Guo X; Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Zheng X; Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Yang A; Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Chen J; Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China. cheney@fjmu.edu.cn.

Cancer Cell Int ; 21(1): 511, 2021 Sep 25.

Article en En | MEDLINE | ID: mdl-34563174

Palabras clave

Bulk gene profiles; Disease progression; Multiple myeloma; Novel signature; Single cell RNA-seq

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Cell Int Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google